Skip to Content

URSODEOXYCHOLIC ACID 500MG FILM-COATED TABLETS

Active substance(s): URSODEOXYCHOLIC ACID

View full screen / Print PDF » Download PDF ⇩
Transcript
Package Leaflet: Information for the User

Ursofalk® 500mg film-coated tablets
(ursodeoxycholic acid)
Read all of this leaflet carefully before you start taking this medicine
because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same as
yours.
• If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet, see
section 4.
• The name of this medicine is Ursofalk 500mg film-coated tablets but
will be referred to as Ursofalk tablets or Ursofalk throughout the
remainder of this leaflet.
What is in this leaflet:
1. What Ursofalk tablets are and what they are used for
2. What you need to know before you take Ursofalk tablets
3. How to take Ursofalk tablets
4. Possible side effects
5. How to store Ursofalk tablets
6. Contents of the pack and other information
1. What Ursofalk tablets are and what they are used for
Ursofalk tablets contain the active substance ursodeoxycholic acid
(UDCA). Small amounts of UDCA are found in human bile.
Ursofalk tablets are used:
• for the treatment of primary biliary cirrhosis (PBC) a condition where
the bile ducts in the liver become damaged leading to a build-up of bile.
This may cause scarring of the liver (cirrhosis of the liver). The liver
should not be so damaged that it is not functioning properly.
• to dissolve cholesterol gallstones. These stones must not be visible on
a plain X-ray (radiolucent) and be no larger than 15 mm in diameter
because they will not dissolve with UDCA. The gall bladder must still
be working despite the gallstone(s).
• for liver disease associated with a condition called cystic fibrosis in
children aged 6 to 18 years.
2. What you need to know before you take Ursofalk tablets
Do NOT take Ursofalk tablets if:
• You are, or have been told you are, allergic (hypersensitive) to bile
acids like UDCA or to any of the other ingredients of this medicine
(listed in section 6).
• You have an acute inflammation of the gall bladder or biliary tract.
• You have a blockage of the common bile duct or cystic duct
(obstruction of the biliary tract).
• You have frequent cramp-like upper abdomen pain (biliary colic).
• Your doctor has said you have calcified gallstones (they are visible on
an x-ray).
• Your gall bladder does not work properly.
• You are a child with biliary atresia and have poor bile flow, even after
surgery.
Please ask your doctor about the conditions mentioned above. You
should also ask if you have previously had any of these conditions or if
you are unsure whether you have any of them.
Warnings and precautions:
Talk to your doctor or pharmacist before taking Ursofalk tablets.
Your doctor should test your liver function regularly every 4 weeks for the
first 3 months of treatment. After this time, it should be monitored at 3
month intervals.
When used in the treatment of PBC, in rare cases the symptoms may
worsen at the beginning of treatment. If this happens, please speak to
your doctor about reducing your initial dose.
When used to dissolve gallstones, your doctor should arrange for a scan
of your gall bladder after the first 6-10 months of treatment.
Please talk to your doctor immediately if you have diarrhoea, as this may
require a reduction in the dose or discontinuation of the treatment with
Ursofalk tablets.

Other medicines and Ursofalk tablets
Please tell your doctor if you are taking or have recently taken or might
take any other medicines.
The effects of these medicines may be altered:
A reduction in the effects of the following medicines is possible when
taking Ursofalk tablets:
• colestyramine, colestipol (to lower blood lipids) or antacids containing
aluminium hydroxide or smectite (aluminium oxide).
If you must take medication that contains any of these ingredients, it
must be taken at least two hours before or after Ursofalk tablets.
• ciprofloxacin, dapsone (antibiotics), nitrendipine (used to treat high
blood pressure) and other medicines which are metabolised in a similar
way. It may be necessary for your doctor to alter the dose of these
medicines.
A change in the effects of the following medicines is possible when
taking Ursofalk tablets:
• ciclosporin (to reduce the activity of the immune system). If you are
being treated with ciclosporin, your doctor should check the amount of
ciclosporin in your blood. Your doctor will adjust its dose, if necessary.
• rosuvastatin (for high cholesterol and related conditions).
If you are taking Ursofalk tablets for the dissolution of gallstones, please
inform your doctor in case you are taking any medicines that contain
oestrogenic hormones or blood cholesterol lowering agents such as
clofibrate. These medicines stimulate the formation of gallstones, which is
a counter-effect to the treatment with Ursofalk.
Please tell your doctor or pharmacist if you are taking or have recently
taken any other medicines, even if they are medicines obtainable without
a prescription. Treatment with Ursofalk tablets may still be allowed. Your
doctor will know what is right for you.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are
planning to have a baby, ask your doctor or pharmacist for advice before
taking this medicine.
Pregnancy: You should not take Ursofalk during pregnancy unless your
doctor thinks it is absolutely necessary.
Women of child-bearing potential: Even if you are not pregnant, you
should still discuss this possibility with your doctor. Before starting
treatment with Ursofalk, your doctor will check that you are not pregnant
and review your contraceptive method to make sure it is appropriate.
Breastfeeding: Tell your doctor if you are breastfeeding or about to start
breastfeeding.
Driving and using machines:
No particular precautions are necessary.
3. How to take Ursofalk tablets
Always take Ursofalk tablets exactly as your doctor has told you. You
should check with your doctor or pharmacist if you are not sure.
For the treatment of primary biliary cirrhosis
(inflammation of the bile ducts)
Dosage
During the first 3 months of treatment, you should take Ursofalk tablets in
divided doses during the day. As liver function tests improve, the total
daily dose may be taken once a day in the evening.
Ursofalk 500mg film-coated tablets
Daily
Body
First 3 months
Subsequently
dose
weight
(mg/kg
Evening
BW (kg)
Morning Midday Evening
BW)
(once daily)
47 – 62
12 – 16
½
½
½

63 – 78
13 – 16
½
½
1
2
79 – 93
13 – 16
½
1
1

94 – 109
14 – 16
1
1
1
3
over 110
1
1


How to take Ursofalk tablets
The tablet can be divided into equal doses. Swallow the tablets with a
drink of water or other liquid. Do not crush or chew the tablets. Take the
tablets regularly.

Duration of treatment
Ursofalk tablets can be continued indefinitely in cases of PBC.
To dissolve cholesterol gallstones
Dosage
Approximately 10 mg per kg body weight (BW) daily, as follows:
up to 60 kg
1 tablet
61 – 80 kg
1½ tablets
81 – 100 kg
2 tablets
over 100 kg
2½ tablets
How to take Ursofalk tablets
The tablet can be divided into equal doses. Swallow the tablets with a
drink of water or other liquid.
Do not crush or chew the tablets. Take the tablets in the evening at
bedtime. Take the tablets regularly.
Duration of treatment
It generally takes 6 - 24 months to dissolve gallstones. If there is no
reduction in the size of the gallstones after 12 months, therapy should be
stopped.
Every 6 months, your doctor should check whether the treatment is
working. At each of these follow-up examinations, it should be checked
whether calcification of the stones has occurred since the last time. If this
is the case, your doctor will stop the treatment.
Both indications:
Ursofalk capsules or Ursofalk suspension are available if you weigh less
than 47 kg or cannot swallow tablets.
Use in elderly:
There is no evidence to suggest that any alteration in the adult dose is
needed but the relevant precautions should be taken into account.
Use in children and adolescents:
There are no age limits to the use of Ursofalk tablets. The administration
of Ursofalk tablets is based on body weight and the medical condition.
Use in children (6 to 18 years) for treatment of liver disease
associated with cystic fibrosis
Dosage
The recommended daily dose is 20 mg per kg body weight, divided in 2-3
doses. Your doctor may want to increase the dose further to 30mg per kg
body weight daily if necessary.
Body weight
Daily dose
Ursofalk 500mg film-coated tablets
BW (kg)
(mg/kg BW)
Morning
Midday
Evening
20 – 29
17-25
½

½
30 – 39
19-25
½
½
½
40 – 49
20-25
½
½
1
50 – 59
21-25
½
1
1
60 – 69
22-25
1
1
1
70 – 79
22-25
1
1

80 – 89
22-25
1


90 – 99
23-25



100 – 109
23-25


2
>110

2
2
How to take Ursofalk tablets
The tablet can be divided into equal doses. Swallow the tablets with a
drink of water or other liquid. Do not crush or chew the tablets. Take the
tablets regularly.
Duration of treatment
Treatment can be continued long term (up to 12 years) in children with
cystic fibrosis associated hepatobiliary disorders.
If you feel that the effect of Ursofalk 500mg film-coated tablets is too
strong or too weak, please talk to your doctor or pharmacist.
If you take more Ursofalk tablets than you should:
Diarrhoea may occur as a result of overdose. Please inform your doctor
immediately if you have persistent diarrhoea. If you do suffer from
diarrhoea, make sure you drink enough liquids to replace your fluid and
salt balance.
If you forget to take Ursofalk tablets
Do not take more tablets the next time, but just continue the treatment
with the prescribed dose.
If you stop taking Ursofalk tablets:
Always speak to your doctor before you decide to interrupt treatment with
Ursofalk tablets or decide to stop your treatment early.

4. Possible side effects
Like all medicines, Ursofalk tablets can cause side effects, although not
everybody gets them.
Common side effects (occurring in less than 1 in 10 but more than 1 in
100 patients):
• soft, loose stools or diarrhoea
Very rare side effects (occurring in less than 1 in 10,000 patients):
• during the treatment of primary biliary cirrhosis: severe right-sided
upper abdominal pain, severe worsening of liver cirrhosis which
partially eases after treatment is discontinued
• hardening of gallstones due to build-up of calcium. There are no
additional symptoms of this but it will show up in tests
• nettle rash (urticaria)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes
any possible side effects not listed in this leaflet.
You can also report side effects directly via: Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the
safety of this medicine.
5. How to store Ursofalk tablets
• Keep out of the sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not use Ursofalk after the expiry date which is stated on the label.
The expiry date refers to the last day of that month.
• If your tablets become discoloured or show any sign of deterioration,
return them to your pharmacist.
• Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer
required. These measures will help to protect the environment.
6. Contents of the pack and other information
What Ursofalk 500mg film-coated tablets contain
Each tablet contains 500mg of the active ingredient ursodeoxycholic acid.
The other ingredients are:
Tablet core: magnesium stearate, polysorbate 80, povidone K 25,
microcrystalline cellulose, colloidal anhydrous silica, crospovidone (type
A) and talc.
Coating: hypromellose, macrogol 6000 and talc.
What Ursofalk 500mg film-coated tablets look like and contents of
the pack
Ursofalk 500mg film-coated tablets are white, oval, biconvex and scored
on both sides. Ursofalk comes in PVC/PVDC/aluminium blister strips in
packs of 50 and 100 tablets.
Manufacturer
Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108 Freiburg, Germany.
Procured from within the EU by the Product Licence holder:
MPT Pharma Ltd, Westgate Business Park, Unit 5-7 Tintagel Way,
Aldridge, Walsall WS9 8ER.
Repackaged by MPT Pharma Ltd.
PL: 33532/0622

POM

Leaflet date: 13th November 2015
Leaflet code: xxxxxxxxx
Other sources of information:
Further information, help, advice and details of local support groups can
be found at:
The PBC Foundation
The British Liver Trust
2 York Place
2 Southampton Road
Edinburgh
Ringwood
Scotland
England
EH1 3EP
BH24 1HY
Telephone: +44 (0) 131 556 6811
Telephone: +44 (0) 1425 481320
www.pbcfoundation.org.uk
www.britishlivertrust.org.uk
Ursofalk® is a registered trademark of Dr. Falk Pharma GmbH.

Package Leaflet: Information for the User

Ursodeoxycholic acid 500mg film-coated tablets
Read all of this leaflet carefully before you start taking this medicine
because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same as
yours.
• If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet, see
section 4.
• The name of this medicine is Ursodeoxycholic acid 500mg film-coated
tablets but will be referred to as Ursodeoxycholic acid tablets or
Ursodeoxycholic acid throughout the remainder of this leaflet.
What is in this leaflet:
1. What Ursodeoxycholic acid tablets are and what they are used for
2. What you need to know before you take Ursodeoxycholic acid tablets
3. How to take Ursodeoxycholic acid tablets
4. Possible side effects
5. How to store Ursodeoxycholic acid tablets
6. Contents of the pack and other information
1. What Ursodeoxycholic acid tablets are and what they are used
for
Ursodeoxycholic acid tablets contain the active substance
ursodeoxycholic acid (UDCA). Small amounts of UDCA are found in
human bile.
Ursodeoxycholic acid tablets are used:
• for the treatment of primary biliary cirrhosis (PBC) a condition where
the bile ducts in the liver become damaged leading to a build-up of bile.
This may cause scarring of the liver (cirrhosis of the liver). The liver
should not be so damaged that it is not functioning properly.
• to dissolve cholesterol gallstones. These stones must not be visible on
a plain X-ray (radiolucent) and be no larger than 15 mm in diameter
because they will not dissolve with UDCA. The gall bladder must still
be working despite the gallstone(s).
• for liver disease associated with a condition called cystic fibrosis in
children aged 6 to 18 years.
2. What you need to know before you take Ursodeoxycholic acid
tablets
Do NOT take Ursodeoxycholic acid tablets if:
• You are, or have been told you are, allergic (hypersensitive) to bile
acids like UDCA or to any of the other ingredients of this medicine
(listed in section 6).
• You have an acute inflammation of the gall bladder or biliary tract.
• You have a blockage of the common bile duct or cystic duct
(obstruction of the biliary tract).
• You have frequent cramp-like upper abdomen pain (biliary colic).
• Your doctor has said you have calcified gallstones (they are visible on
an x-ray).
• Your gall bladder does not work properly.
• You are a child with biliary atresia and have poor bile flow, even after
surgery.
Please ask your doctor about the conditions mentioned above. You
should also ask if you have previously had any of these conditions or if
you are unsure whether you have any of them.
Warnings and precautions:
Talk to your doctor or pharmacist before taking Ursodeoxycholic acid
tablets.
Your doctor should test your liver function regularly every 4 weeks for the
first 3 months of treatment. After this time, it should be monitored at 3
month intervals.
When used in the treatment of PBC, in rare cases the symptoms may
worsen at the beginning of treatment. If this happens, please speak to
your doctor about reducing your initial dose.
When used to dissolve gallstones, your doctor should arrange for a scan
of your gall bladder after the first 6-10 months of treatment.
Please talk to your doctor immediately if you have diarrhoea, as this may
require a reduction in the dose or discontinuation of the treatment with
Ursodeoxycholic acid tablets.

Other medicines and Ursodeoxycholic acid tablets
Please tell your doctor if you are taking or have recently taken or might
take any other medicines.
The effects of these medicines may be altered:
A reduction in the effects of the following medicines is possible when
taking Ursodeoxycholic acid tablets:
• colestyramine, colestipol (to lower blood lipids) or antacids containing
aluminium hydroxide or smectite (aluminium oxide).
If you must take medication that contains any of these ingredients, it
must be taken at least two hours before or after Ursodeoxycholic acid
tablets.
• ciprofloxacin, dapsone (antibiotics), nitrendipine (used to treat high
blood pressure) and other medicines which are metabolised in a similar
way. It may be necessary for your doctor to alter the dose of these
medicines.
A change in the effects of the following medicines is possible when
taking Ursodeoxycholic acid tablets:
• ciclosporin (to reduce the activity of the immune system). If you are
being treated with ciclosporin, your doctor should check the amount of
ciclosporin in your blood. Your doctor will adjust its dose, if necessary.
• rosuvastatin (for high cholesterol and related conditions).
If you are taking Ursodeoxycholic acid tablets for the dissolution of
gallstones, please inform your doctor in case you are taking any
medicines that contain oestrogenic hormones or blood cholesterol
lowering agents such as clofibrate. These medicines stimulate the
formation of gallstones, which is a counter-effect to the treatment with
Ursodeoxycholic acid.
Please tell your doctor or pharmacist if you are taking or have recently
taken any other medicines, even if they are medicines obtainable without
a prescription. Treatment with Ursodeoxycholic acid tablets may still be
allowed. Your doctor will know what is right for you.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are
planning to have a baby, ask your doctor or pharmacist for advice before
taking this medicine.
Pregnancy: You should not take Ursodeoxycholic acid during pregnancy
unless your doctor thinks it is absolutely necessary.
Women of child-bearing potential: Even if you are not pregnant, you
should still discuss this possibility with your doctor. Before starting
treatment with Ursodeoxycholic acid, your doctor will check that you are
not pregnant and review your contraceptive method to make sure it is
appropriate.
Breastfeeding: Tell your doctor if you are breastfeeding or about to start
breastfeeding.
Driving and using machines:
No particular precautions are necessary.
3. How to take Ursodeoxycholic acid tablets
Always take Ursodeoxycholic acid tablets exactly as your doctor has told
you. You should check with your doctor or pharmacist if you are not sure.
For the treatment of primary biliary cirrhosis
(inflammation of the bile ducts)
Dosage
During the first 3 months of treatment, you should take Ursodeoxycholic
acid tablets in divided doses during the day. As liver function tests
improve, the total daily dose may be taken once a day in the evening.
Ursodeoxycholic acid 500mg film-coated tablets
Daily
Body
First 3 months
Subsequently
dose
weight
(mg/kg
Evening
BW (kg)
Morning Midday Evening
BW)
(once daily)
47 – 62
12 – 16
½
½
½

63 – 78
13 – 16
½
½
1
2
79 – 93
13 – 16
½
1
1

94 – 109
14 – 16
1
1
1
3
over 110
1
1


How to take Ursodeoxycholic acid tablets
The tablet can be divided into equal doses. Swallow the tablets with a
drink of water or other liquid. Do not crush or chew the tablets. Take the
tablets regularly.

Duration of treatment
Ursodeoxycholic acid tablets can be continued indefinitely in cases of
PBC.
To dissolve cholesterol gallstones
Dosage
Approximately 10 mg per kg body weight (BW) daily, as follows:
up to 60 kg
1 tablet
61 – 80 kg
1½ tablets
81 – 100 kg
2 tablets
over 100 kg
2½ tablets
How to take Ursodeoxycholic acid tablets
The tablet can be divided into equal doses. Swallow the tablets with a
drink of water or other liquid.
Do not crush or chew the tablets. Take the tablets in the evening at
bedtime. Take the tablets regularly.
Duration of treatment
It generally takes 6 - 24 months to dissolve gallstones. If there is no
reduction in the size of the gallstones after 12 months, therapy should be
stopped.
Every 6 months, your doctor should check whether the treatment is
working. At each of these follow-up examinations, it should be checked
whether calcification of the stones has occurred since the last time. If this
is the case, your doctor will stop the treatment.
Both indications:
Ursodeoxycholic acid capsules or Ursodeoxycholic acid suspension are
available if you weigh less than 47 kg or cannot swallow tablets.
Use in elderly:
There is no evidence to suggest that any alteration in the adult dose is
needed but the relevant precautions should be taken into account.
Use in children and adolescents:
There are no age limits to the use of Ursodeoxycholic acid tablets. The
administration of Ursodeoxycholic acid tablets is based on body weight
and the medical condition.
Use in children (6 to 18 years) for treatment of liver disease
associated with cystic fibrosis
Dosage
The recommended daily dose is 20 mg per kg body weight, divided in 2-3
doses. Your doctor may want to increase the dose further to 30mg per kg
body weight daily if necessary.
Body weight
Daily dose
Ursodeoxycholic acid 500mg
BW (kg)
(mg/kg BW)
film-coated tablets
Morning
Midday
Evening
20 – 29
17-25
½

½
30 – 39
19-25
½
½
½
40 – 49
20-25
½
½
1
50 – 59
21-25
½
1
1
60 – 69
22-25
1
1
1
70 – 79
22-25
1
1

80 – 89
22-25
1


90 – 99
23-25



100 – 109
23-25


2
>110

2
2
How to take Ursodeoxycholic acid tablets
The tablet can be divided into equal doses. Swallow the tablets with a
drink of water or other liquid. Do not crush or chew the tablets. Take the
tablets regularly.

If you stop taking Ursodeoxycholic acid tablets:
Always speak to your doctor before you decide to interrupt treatment with
Ursodeoxycholic acid tablets or decide to stop your treatment early.
4. Possible side effects
Like all medicines, Ursodeoxycholic acid tablets can cause side effects,
although not everybody gets them.
Common side effects (occurring in less than 1 in 10 but more than 1 in
100 patients):
• soft, loose stools or diarrhoea
Very rare side effects (occurring in less than 1 in 10,000 patients):
• during the treatment of primary biliary cirrhosis: severe right-sided
upper abdominal pain, severe worsening of liver cirrhosis which
partially eases after treatment is discontinued
• hardening of gallstones due to build-up of calcium. There are no
additional symptoms of this but it will show up in tests
• nettle rash (urticaria)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes
any possible side effects not listed in this leaflet.
You can also report side effects directly via: Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the
safety of this medicine.
5. How to store Ursodeoxycholic acid tablets
• Keep out of the sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not use Ursodeoxycholic acid after the expiry date which is stated
on the label. The expiry date refers to the last day of that month.
• If your tablets become discoloured or show any sign of deterioration,
return them to your pharmacist.
• Medicines should not be disposed of via wastewater or household
waste. Ask your pharmacist how to dispose of medicines no longer
required. These measures will help to protect the environment.
6. Contents of the pack and other information
What Ursodeoxycholic acid 500mg film-coated tablets contain
Each tablet contains 500mg of the active ingredient ursodeoxycholic acid.
The other ingredients are:
Tablet core: magnesium stearate, polysorbate 80, povidone K 25,
microcrystalline cellulose, colloidal anhydrous silica, crospovidone (type
A) and talc.
Coating: hypromellose, macrogol 6000 and talc.
What Ursodeoxycholic acid 500mg film-coated tablets look like and
contents of the pack
Ursodeoxycholic acid 500mg film-coated tablets are white, oval, biconvex
and scored on both sides. Ursodeoxycholic acid comes in
PVC/PVDC/aluminium blister strips in packs of 50 and 100 tablets.
Manufacturer
Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108 Freiburg, Germany.
Procured from within the EU by the Product Licence holder:
MPT Pharma Ltd, Westgate Business Park, Unit 5-7 Tintagel Way,
Aldridge, Walsall WS9 8ER.

Duration of treatment
Treatment can be continued long term (up to 12 years) in children with
cystic fibrosis associated hepatobiliary disorders.

Repackaged by MPT Pharma Ltd.

If you feel that the effect of Ursodeoxycholic acid 500mg film-coated
tablets is too strong or too weak, please talk to your doctor or pharmacist.

Leaflet date: 13th November 2015
Leaflet code: xxxxxxxxx

If you take more Ursodeoxycholic acid tablets than you should:
Diarrhoea may occur as a result of overdose. Please inform your doctor
immediately if you have persistent diarrhoea. If you do suffer from
diarrhoea, make sure you drink enough liquids to replace your fluid and
salt balance.

Other sources of information:
Further information, help, advice and details of local support groups can
be found at:
The PBC Foundation
The British Liver Trust
2 York Place
2 Southampton Road
Edinburgh
Ringwood
Scotland
England
EH1 3EP
BH24 1HY
Telephone: +44 (0) 131 556 6811 Telephone: +44 (0) 1425 481320
www.pbcfoundation.org.uk
www.britishlivertrust.org.uk

If you forget to take Ursodeoxycholic acid tablets
Do not take more tablets the next time, but just continue the treatment
with the prescribed dose.

PL: 33532/0622

POM

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide